New Clicks South Africa (Pty) Ltd v Sharp Move Trading 107 (Pty) Ltd (106/LM/OCT08) [2009] ZACT 4 (14 January 2009)
The Tribunal found that the proposed merger between New Clicks and Sharp Move would not result in any substantial lessening or prevention of competition in the relevant pharmaceutical market. The combined market share post-merger would be 6.4%, which is not significant enough to raise competition concerns. Furthermore, the vertical integration resulting from New Clicks supplying Sharp Move with pharmaceutical products does not raise foreclosure concerns, as Sharp Move's previous supplier is owned by its shareholders and there are many alternative suppliers in the market. The Tribunal also noted the absence of any public interest issues. Accordingly, the merger was approved without...
- Citation
- [2009] ZACT 4
- Parties
- Applicant: New Clicks South Africa (Pty) Ltd; Respondent: Sharp Move Trading 107 (Pty) Ltd
- Court
- Competition Tribunal
- Jurisdiction
- South Africa
- Judgment Date
- 14 January 2009
- Case Number
- 106/LM/OCT08
- Procedural Posture
- Merger Application / Approval
- Outcome
- Merger approved without conditions.
- Judges
- D Lewis, N Manoim, Y Carrim
- Legal Topics
- Horizontal Merger, Vertical Integration, Market Share Analysis, Foreclosure Concerns
Case Brief
Summary, issues, holding and outcome
More case intelligence is available
Unlock the full research layer for this judgment.
Parties
New Clicks South Africa (Pty) Ltd
Applicant
Sharp Move Trading 107 (Pty) Ltd
Respondent
Procedural Posture
Merger Application / Approval
Legal Issues
- 1 Whether the proposed merger will substantially lessen or prevent competition in the relevant pharmaceutical market.
- 2 Whether the merger raises any foreclosure concerns due to vertical integration.
- 3 Whether there are any public interest issues arising from the merger.
Ratio Decidendi
The Tribunal found that the proposed merger between New Clicks and Sharp Move would not result in any substantial lessening or prevention of competition in the relevant pharmaceutical market. The combined market share post-merger would be 6.4%, which is not significant enough to raise competition concerns. Furthermore, the vertical integration resulting from New Clicks supplying Sharp Move with pharmaceutical products does not raise foreclosure concerns, as Sharp Move's previous supplier is owned by its shareholders and there are many alternative suppliers in the market. The Tribunal also noted the absence of any public interest issues. Accordingly, the merger was approved without...
Court Disposition
Merger approved without conditions.
Orders
- The merger between New Clicks South Africa (Pty) Ltd and Sharp Move Trading 107 (Pty) Ltd is approved without conditions.
Full Case Text
Judgment text and source record
Sign in to read
Sign in to read the full judgment text
Sign in to read the full judgment text. Downloads and additional research tools may depend on your plan.
Sign in to read the full judgment